NCT05794191View on ClinicalTrials.gov

A Study To Learn About The Effects Of Pneumococcal Vaccine In People With HIV

CompletedOBSERVATIONAL
Enrollment

350,399

Participants

Timeline

Start Date

March 22, 2023

Primary Completion Date

August 15, 2024

Study Completion Date

August 15, 2024

Conditions
HIVPneumoniaInfections, Pneumococcal
Interventions
BIOLOGICAL

Vaccine Administration

PCV13 administration

Trial Locations (1)

10001

Pfizer, New York

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT05794191 - A Study To Learn About The Effects Of Pneumococcal Vaccine In People With HIV | Biotech Hunter | Biotech Hunter